Litcius/Paper detail

OA04.05 SHR-A1921, A TROP-2 Targeted Antibody-Drug Conjugate (ADC), In Patients (pts) with Advanced Small-Cell Lung Cancer (SCLC)

Jing Wang, Lingxiang Wu, Xi Li, Na Xing, Shuang Zhang, Zhuolun Song, Lan Chen, Qi Dang, Chao Liu, Ye Li, H. Eric Xu, J. Zhong, Yufeng Wu, Zhenyang Lin, Zhenhai Zhang, Shuai Wang

2024Journal of Thoracic Oncology16 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAntibody-drug conjugateLung cancerConjugateDrugOncologyInternal medicineAntibodyPharmacologyImmunologyMonoclonal antibodyMathematical analysisMathematicsLung Cancer Research StudiesHER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations
OA04.05 SHR-A1921, A TROP-2 Targeted Antibody-Drug Conjugate (ADC), In Patients (pts) with Advanced Small-Cell Lung Cancer (SCLC) | Litcius